+ Follow PHARMACYCLICS AND JANSSEN BIOTECH INC Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1257009
[Title] => FDA approves new drug for rare blood cancer
[Summary] => The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.
[DatePublished] => 2013-11-15 03:26:01
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
)
)
)
PHARMACYCLICS AND JANSSEN BIOTECH INC
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1257009
[Title] => FDA approves new drug for rare blood cancer
[Summary] => The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.
[DatePublished] => 2013-11-15 03:26:01
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
)
)
)
abtest
November 15, 2013 - 3:26am